Tag: NIH

Greenstone Biosciences Receives NIH R61 Grant to Advance Cardiac Fibrosis Therapeutics for Duchenne Muscular Dystrophy

Financial by 0 comments

PALO ALTO, Calif.–(BUSINESS WIRE)– #BioPharma–Greenstone Biosciences, a biotechnology company advancing New Approach Methodologies (NAMs) for drug discovery, today announced that it has received a Catalyze R61 award from the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The award funds a research program to discover novel drug candidates for myocardial fibrosis and dilated cardiomyopathy in Duchenne muscular dystrophy (DMD). DMD is a rare genet

Continue Reading →

Feinstein Investigators Awarded $2.8 Million To Study Vascular Injury After Radiation Exposure

Radiology by 0 comments

MANHASSET, N.Y., July 14, 2017 /PRNewswire-USNewswire/ — Feinstein Institute for Medical Research investigators Weng-Lang Yang, PhD, and Ping Wang, MD, have been awarded a five-year, $2.8 million U01 grant from the National Institutes of Health’s (NIH) National Institute of Allergies and Infectious Diseases (NIAID) to investigate the use of the human hormone ghrelin to reduce organ injury after […]

Continue Reading →